WebinarsNew
Deep DiveNew
Explore Business Standard
Max Healthcare Institute Ltd will invest Rs 6,000 crore by 2028 to add 3,700 beds across key locations in India, its Chairman and Managing Director Abhay Soi said on Tuesday. Max Healthcare, which operates 22 healthcare facilities with around 5,000 beds currently could have around 30 hospitals by 2028, Soi told PTI. Speaking at the sidelines of the inauguration of Max Super Speciality Hospital, Dwarka, a 300-bed greenfield facility, he said the company will be "reinvesting whatever we generate over the next 10 years to create healthcare assets". "This year alone, we are opening four (hospitals). This (Dwarka) was the first of the four," Soi said. Max Healthcare plans to inaugurate three other hospitals in Mohali, Mumbai, and Saket, New Delhi later this year. The inauguration of the Dwarka hospital is a strategic step in Max Healthcare's broader expansion plan to add 3,700 beds across key locations in India by 2028, the company said. "Some existing hospitals will be expanded and s
Akumentis Healthcare on Wednesday said it has introduced a drug for the treatment of epilepsy. The Mumbai-based company has launched Clasepi, a DCGI-approved prescription cannabidiol (CBD) specifically formulated to address seizures linked with Lennox-Gastaut Syndrome (LGS), Dravet Syndrome, or Tuberous Sclerosis Complex (TSC) in patients aged 1 year and older, it said in a statement. Clinical studies have demonstrated Clasepi's efficacy in reducing seizures, especially in cases where conventional anti-seizure medications have proven ineffective, it added. "We understand the immense physical and emotional toll that frequent seizures can have on patients and their families," Akumentis Executive Director Kanishk Jain said. This is the driving force behind our commitment to developing novel solutions that effectively relieves the complexities of these disorders, he added. According to the World Health Organisation (WHO), epilepsy constitutes a considerable portion of the global disea